Literature DB >> 28043738

Negative impact of prior influenza vaccination on current influenza vaccination among people infected and not infected in prior season: A test-negative case-control study in Japan.

Nobuo Saito1, Kazuhiro Komori2, Motoi Suzuki3, Kounosuke Morimoto3, Takayuki Kishikawa2, Takahiro Yasaka2, Koya Ariyoshi4.   

Abstract

BACKGROUND: Accumulating evidences indicate that repeated influenza vaccination has negative impact on the vaccine effectiveness (VE). However no published studies considered past influenza infection when assessing the VE of repeated vaccination.
METHODS: Prospective surveillance was conducted from 2009 to 2012 at a community hospital on a small island in Japan. The study included all outpatients with an influenza-like illness (ILI) who attended the hospital, and a rapid diagnostic test (RDT) was used to diagnose influenza A/B infection. The VE of trivalent inactivated influenza vaccine (TIV) against medically attended influenza A (MA-fluA) was estimated using a test-negative case-control study design. The influence of TIV in the prior season on VE in the current season was investigated in the context of MA-fluA during the prior season.
RESULTS: During the three influenza seasons, 5838 ILI episodes (4127 subjects) were analysed. Subjects who had an episode of MA-fluA in the prior season were at a significantly lower risk of MA-fluA in the current season (adjusted odds ratio: 0.38, 95% CI: 0.30-0.50). The overall adjusted VE was 28% (95% CI, 14-40). VE was substantially lower in subjects vaccinated in the prior season compared to those who had not been vaccinated in prior season (19%; 95% CI: 0-35 vs 46%; 95% CI: 26-60, test for interaction, P value <0.05). In subjects who did not have MA-fluA in the prior season showed the attenuation of VE due to repeated vaccination (13%; 95% CI: -7 to 30 vs 44%; 95% CI: 24-59, test for interaction, P<0.05). However this effect was not detected in subjects who had contracted MA-fluA in the prior season.
CONCLUSIONS: Negative effects of repeated vaccination were significant among those without history of MA-fluA in the prior season.
Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Influenza; Past influenza exposure; Repeated vaccination; Vaccine effectiveness

Mesh:

Substances:

Year:  2016        PMID: 28043738     DOI: 10.1016/j.vaccine.2016.11.024

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  16 in total

Review 1.  Models for predicting the evolution of influenza to inform vaccine strain selection.

Authors:  Joseph K Agor; Osman Y Özaltın
Journal:  Hum Vaccin Immunother       Date:  2018-02-12       Impact factor: 3.452

2.  The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology.

Authors:  Huiying Chua; Shuo Feng; Joseph A Lewnard; Sheena G Sullivan; Christopher C Blyth; Marc Lipsitch; Benjamin J Cowling
Journal:  Epidemiology       Date:  2020-01       Impact factor: 4.822

3.  Imprinting of Repeated Influenza A/H3 Exposures on Antibody Quantity and Antibody Quality: Implications for Seasonal Vaccine Strain Selection and Vaccine Performance.

Authors:  Martina Kosikova; Lei Li; Peter Radvak; Zhiping Ye; Xiu-Feng Wan; Hang Xie
Journal:  Clin Infect Dis       Date:  2018-10-30       Impact factor: 9.079

4.  A systematic review and meta-analysis of the direct epidemiological and economic effects of seasonal influenza vaccination on healthcare workers.

Authors:  Chisato Imai; Michiko Toizumi; Lisa Hall; Stephen Lambert; Kate Halton; Katharina Merollini
Journal:  PLoS One       Date:  2018-06-07       Impact factor: 3.240

5.  Exploring the effect of previous inactivated influenza vaccination on seasonal influenza vaccine effectiveness against medically attended influenza: Results of the European I-MOVE multicentre test-negative case-control study, 2011/2012-2016/2017.

Authors:  Marta Valenciano; Esther Kissling; Amparo Larrauri; Baltazar Nunes; Daniela Pitigoi; Joan O'Donnell; Annicka Reuss; Judit Krisztina Horváth; Iwona Paradowska-Stankiewicz; Caterina Rizzo; Alessandra Falchi; Isabelle Daviaud; Mia Brytting; Adam Meijer; Bernard Kaic; Alin Gherasim; Ausenda Machado; Alina Ivanciuc; Lisa Domegan; Brunhilde Schweiger; Annamária Ferenczi; Monika Korczyńska; Antonino Bella; Ana-Maria Vilcu; Anne Mosnier; Katherina Zakikhany; Marit de Lange; Sanja Kurečić Filipovićović; Kari Johansen; Alain Moren
Journal:  Influenza Other Respir Viruses       Date:  2018-05-09       Impact factor: 4.380

6.  Prime-pull vaccination with a plant-derived virus-like particle influenza vaccine elicits a broad immune response and protects aged mice from death and frailty after challenge.

Authors:  Breanna Hodgins; Stephane Pillet; Nathalie Landry; Brian J Ward
Journal:  Immun Ageing       Date:  2019-11-04       Impact factor: 6.400

7.  Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza pneumonia among adults aged ≥65 years in Japan.

Authors:  Motoi Suzuki; Naoko Katsurada; Minh Nhat Le; Norihiro Kaneko; Makito Yaegashi; Naoto Hosokawa; Yoshihito Otsuka; Masahiro Aoshima; Lay Myint Yoshida; Konosuke Morimoto
Journal:  Vaccine       Date:  2018-05-17       Impact factor: 3.641

8.  Effectiveness of influenza vaccine in preventing medically-attended influenza virus infection in primary care, Israel, influenza seasons 2014/15 and 2015/16.

Authors:  Hamutal Yaron-Yakoby; Hanna Sefty; Rakefet Pando; Rita Dichtiar; Mark A Katz; Yaniv Stein; Michal Mandelboim; Ella Mendelson; Tamy Shohat; Aharona Glatman-Freedman
Journal:  Euro Surveill       Date:  2018-02

9.  Low coverage rate and awareness of influenza vaccine among older people in Shanghai, China: A cross-sectional study.

Authors:  Chuchu Ye; Weiping Zhu; Jianxing Yu; Zhongjie Li; Wenbiao Hu; Lipeng Hao; Yuanping Wang; Hongmei Xu; Qiao Sun; Genming Zhao
Journal:  Hum Vaccin Immunother       Date:  2018-07-26       Impact factor: 3.452

Review 10.  The Effects of Pre-Existing Antibodies on Live-Attenuated Viral Vaccines.

Authors:  Darren Z L Mok; Kuan Rong Chan
Journal:  Viruses       Date:  2020-05-08       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.